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S U M M A R Y
Objective: The objective of this retrospective study is to analyze whether preoperative functional imaging
studies using FDG-PET and MEG enable prediction of postoperative seizure outcomes.
Methods: Thirty-six patients with intractable temporal lobe epilepsy were studied. Asymmetry index of
tCMRgluc (PET-AI) and the equivalent current dipole intensity of ﬁrst response of SEF (SEF-AI) were
determined preoperatively using 18F-ﬂuorodeoxyglucose-positron emission tomography (FDG-PET) and
magnetoencephalography (MEG), respectively. Seizure outcomes were evaluated according to the
classiﬁcation proposed by the International League Against Epilepsy (ILAE) at least 24 months after
resection of epileptic focuses. Twelve healthy volunteers were included in this study to determine the
normal value.
Results: Quantitative analysis revealed mean PET-AI in the patients was 5.4  5.2% (signiﬁcantly different
from normal controls); mean SEF-AI was 25.2  20.6% (not signiﬁcantly different). PET-AI was positive
(indicative of epileptic focus) in 29 of 36 patients (80.6%), while SEF-AI was positive in 17 of 36 patients
(47.2%). Although no signiﬁcant correlation between PET-AI and SEF-AI was noted (r = 0.43), concordant
asymmetry in both PET-AI and SEF-AI was signiﬁcantly associated with better seizure outcome than
discordant or paradoxical asymmetry of both factors (p < 0.01).
Conclusions: The results suggest that quantitative analysis of tCMRgluc with SEF may be helpful in
characterizing the preoperative epileptogenic condition and predicting postoperative seizure outcome in
patients with temporal lobe epilepsy, although a constellation of developmental brain abnormalities and
environmental factors that together produce epilepsy need to be further explored.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
journa l homepage: www.e lsev ier .com/ locate /yse izIntroduction
Our understanding of medial temporal lobe epilepsy has
advanced in recent times following progress in histopathology,
electrophysiology, and functional neuroimaging; however, our
understanding is incomplete and requires further reﬁnements in
postoperative seizure outcomes. Medial temporal lobe epilepsy is
likely to exist as part of a constellation of developmental brain§ A summary of this articlewas presented at 13thWorld Congress of Neurological
Surgery, Marrakesh, Morocco, June 2005.
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doi:10.1016/j.seizure.2008.05.004abnormalities and environmental factors that together produce
epilepsy.1
We previously used 18F-ﬂuorodeoxyglucose-positron emission
tomography (FDG-PET) and magnetoencephalography (MEG) to
characterize interictal functional properties of the epileptogenic
zone of the temporal lobe in patients with medial temporal lobe
epilepsy.2 We propose that the equivalent current dipole is
distributed in varied ways with the disorder and uncoupling of
glucose metabolism and perfusion in the temporal lobe; however,
the clinical impact of FDG-PET and MEG on postoperative seizure
outcome remains unresolved. Prediction of postoperative seizure
outcome based on preoperative evaluation is not straightforward
because of the diversity and complexity of medial temporal
lobe epilepsy.3–11 Careful preoperative analysis may enable us to
formulate goals for surgical treatment.vier Ltd. All rights reserved.
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functional imaging studies using FDG-PET and MEG enable
prediction of postoperative seizure outcomes. The subjects of
the study comprised 12 normal healthy volunteers and 36 patients
with drug-resistant medial temporal lobe epilepsy who had
surgery at Osaka City University Hospital, Japan, from December
2000 to March 2003; each subject underwent FDG-PET and MEG
on the point aimed at the thalamus and its related cerebral neural
activity.
Patients and methods
Careful preoperative evaluationwas conducted in all patients to
characterize the epileptic condition according to methodology
described previously.2 Brieﬂy, all patients underwent multimodal
evaluation that included magnetic resonance imaging (MRI),
interictal and ictal video-EEG monitoring, FDG-PET, and MEG.
Patient population
Thirty-six consecutive patients (male, n = 16; female, n = 20;
age range, 12–58 years; mean age, 37.2 years) with a medical
history of intractable temporal lobe epilepsy were enrolled in the
present study (Table 1). Patients with any other structural lesions
such as tumors, vascular malformations, cerebral contusions,
cortical anomalies in the thalamus or sensorimotor cortex, or withTable 1
Patient proﬁle and characteristics
Patient number Age Sex MRI Duration (yr
1 40 F Lt HS 34
2 50 F Rt HS 10
3 28 M Lt HS 19
4 37 F Rt HS 17
5 55 F Lt HS, calciﬁcation (multiple) 42
6 29 F Rt HS 22
7 44 M Rt HS, cavernoma (rt frontal) 25
8 21 M Rt HS 17
9 26 F Calciﬁcation (paraventricular) 14
10 37 M Rt HS 37
11 34 M Lt HS 29
12 33 M Lt HS 31
13 35 F Rt HS, CD (rt temporal) 26
14 30 F Lt HS 29
15 44 F Rt HS 24
16 28 M Lt HS 19
17 50 F Lt HS 32
18 36 M Lt HS 33
19 22 F Rt HS 6
20 55 F Lt HS 43
21 31 M Bil. HS 23
22 40 F n.p. 37
23 54 M Rt HS 20
24 25 F Rt HS 13
25 37 F Cerebellar tumor (cavernoma) 36
26 12 F Lt HS 4
27 27 M n.p. 26
28 28 F Lt HS 19
29 58 F n.p. 49
30 34 M Lt HS 19
31 50 M Lt HS 33
32 31 F n.p. 20
33 58 M Lt HS 43
34 34 M Lt HS 14
35 37 F Rt HS 17
36 50 M Cavernoma (Lt temporo-occipital) 20
Mean 37.2 25.1
M: male, F: female, HS: hippocampal sclerosis, ATL: anterior temporal lobectomy with
multiple subpial transection, CD: cortical dysplasia. Outcome: ILAE classiﬁcation, 1 (seiz
year), 4 (four seizure days per year to 50% reduction) and 5 (less than 50% reduction).symptoms related to cervical spondylosis were excluded from the
study. The duration of seizure history ranged from 4 to 49 years,
with mean duration of 25.1 years. All 36 patients subsequently
underwent anterior temporal lobectomy with amygdalo-hippo-
campectomy or selective amygdalo-hippocampectomywith/with-
out multiple subpial transection (MST)12–14 after comprehensive
preoperative evaluation. The present study was approved by the
Ethics Committee of Osaka City University Hospital, and all
patients gave their informed consent on admission to the study.
Magnetic resonance imaging
MRI was performed using a high-resolution 1.5 T scanner
(SIGNA Horizon 1.5 Tesla, GE Yokogawa Medical Systems, Tokyo,
Japan) for all patients. In all patients, multi-directional T1 and T2
images were acquired, and ﬂuid-attenuated inversion recovery
(FLAIR) images were also taken in planes parallel and perpendi-
cular to the long axis of the hippocampus with 3 mm slice
thickness to evaluate the amygdala and hippocampus.
18F-ﬂuorodeoxyglucose-positron emission tomography
Cerebral glucose metabolism was analyzed interictally using a
PET scanner (HEADTOME IV, Shimadzu, Kyoto, Japan) with a
spatial resolution of 4.5 mm (full width half maximum) and a slice
thickness of 6.5 mm (14 slices). Scans were performed unders) Surgery Pathology Follow-up (months) Outcome
Lt ATL HS 63 3
Rt ATL HS 62 3
Lt ATL HS 61 3
Rt ATL HS 59 1
Lt ATL HS 56 2
Rt ATL HS 55 2
Rt ATL HS 54 5
Rt ATL HS 53 1
Lt ATL Normal 50 4
Rt ATL + Lt MST HS 50 3
Lt SAHE + MST HS 47 1
Lt SAHE + MST HS 46 1
Rt SAHE + removal of CD HS, CD 42 1
Lt SAHE + MST HS 41 1
Rt SAHE + MST HS 40 1
Lt SAHE + MST HS 39 1
Lt SAHE + MST HS 38 4
Lt SAHE + MST HS 36 5
Rt SAHE + MST HS 35 1
Lt SAHE + MST HS 35 1
Lt SAHE + MST HS 34 2
Rt SAHE Normal 34 5
Rt SAHE + MST HS 33 1
Rt SAHE + MST HS 32 3
Rt SAHE + MST Normal 32 4
Lt SAHE + MST HS 31 1
Rt SAHE Normal 30 4
Lt SAHE HS 28 4
Lt SAHE Normal 27 4
Lt SAHE HS 26 3
Lt SAHE HS 26 1
Rt SAHE Normal 25 4
Lt SAHE HS 25 1
Lt SAHE HS 25 1
Rt SAHE Normal 24 1
Lt SAHE Normal 24 4
39.4
amygdalo-hippocampectomy, SAHE: selective amygdalo-hippocampectomy, MST:
ure-free; no aura), 2 (aura only; no other seizure), 3 (one to three seizure days per
Figure 1. PET image parallel to the orbitomeatal line containing the bilateral
thalamus. ROI (region of interest) taken of the bilateral thalamus as follows: (1)
right thalamus and (2) left thalamus.
S. Sakamoto et al. / Seizure 18 (2009) 1–6 3ambient resting conditions with eyes covered and ears unplugged
in a quiet environment. After a 4-h fasting period a transmission
scan was obtained; a static 10 min scan was then performed
20 min after injection (within 30 s) of 370 MBq of FDG. The PET
images were reconstructed usingmeasured attenuation correction
with the plane of imaging parallel to the orbitomeatal line. The
cerebral metabolic rate of glucose in the thalamus (tCMRgluc) was
measured by acquiring and analyzing three serial PET images
containing the bilateral thalamus. Regions of interest (ROI) were
determined in the right and left thalamus in each image plane, as
demonstrated in Fig. 1. Mean activity of FDG uptake wasmeasured
and the standardized uptake value (SUV) of FDG was calculated
according the following formula: SUV = [(pixel count/pixel
volume)/(injected radioisotope activity/body weight)]  calibra-
calibration factor. The ﬁnal SUV was determined as the mean
of three serial images. The asymmetry index (AI%) of tCMRglucFigure 2. (A) Somatosensory-evoked magnetic ﬁelds (SEFs) were obtained by applying e
stimulated in this presentation)—sampling rate: 2000 Hz, bandpass ﬁlter: 3–500 Hz, dur
(ECDI), the ﬁrst main component with a latency of approximately 20 ms of SEF, were est
and superimposed onto the patient’s MRI (circle is dipole position and bar is dipole or(PET-AI) was calculated for pairs of symmetrical regions using the
following formula: AI = (Contra  Ipsi)  100/[(Contra + Ipsi)/2].
Positive AI indicates low glucose metabolism on the ipsilateral
thalamus of the epileptic temporal lobe, whereas negative AI
indicates low metabolism on the contralateral thalamus.
Magnetoencephalography
All MEG measurements were performed in a magnetically
shielded room at Osaka City University Hospital using a 160-
channel whole-head type magnetoencephalographic system
(MEG vision PQ1160C, Yokogawa Electric Corporation, Kanazawa,
Japan) with a magnetic ﬁeld resolution of 4 fT/Hz1/2 in the white
noise region. The sensing and reference coils each had a diameter
of 15.5 mm, with a 50 mm base line and 23 mm separation
between each pair of sensing coils. The sensing coils were ﬁrst-
order gradiometers.15
Somatosensory evoked magnetic ﬁelds (SEFs) were obtained
by applying electrical stimuli in 0.1 ms pulses to themedian nerve
in the wrist with the cathode placed proximally. A forceps-like
apparatus was used to ﬁx the electrodes to the wrist and apply
maximum stimulus to the median nerve. Four hundred stimuli
were presented at a rate of 2 Hz, with responses passing through a
3–500 Hz bandpass ﬁlter. The sampling rate was 2000 Hz. The
stimulation intensitywas set at 1.5 times the threshold of a thenar
muscle twitch, where the intensity of the dipole moment is
saturated. The ﬁrst main component of the SEF, with a latency of
approximately 20 ms, is referred to as N20m and corresponds to
N20 of the somatosensory evoked potentials (SSEPs). MRI was
performed on all subjects. The MEG coordinates were transferred
to the MRI coordinate system and localized using skin markers
and coils. Single equivalent source dipole locations were
estimated using the least-squares method with a spherically
symmetrical headmodel. Dipoleswith a goodness of ﬁt (GOF) of at
least 95% were used to determine dipole intensity (Fig. 2).
Equivalent current dipole intensity (ECDI) of N20mwasmeasured
twice in each hemisphere and the ﬁnal intensity was determined
as a mean. The asymmetry index (AI%) of ECDI (SEF-AI) was
calculated using the following formula: AI = (Contra  Ipsi)
 100/[(Contra + Ipsi)/2]. Positive AI indicates low neural activity
in the ipsilateral cerebral hemisphere of the epileptic temporallectrical stimuli to the unilateral median nerve in each wrist (right median nerve is
ation: 0.1 ms, averaging: 400 times. (B) Equivalent current dipole intensity of N20m
imated using the least-squares method with a spherically symmetrical head model
ientation). Goodness of ﬁt: >95%.
Table 2
Results of investigation and classiﬁcation with FDG-PET and MEG
Patient number PET-AI SEF-AI Group
1 6.3 16.9 1
2 2.0 18.8 1
3 1.4 37.0 2
4 7.3 28.0 1
5 4.6 32.9 2
6 6.2 5.6 1
7 6.1 28.0 2
8 11.1 20.5 1
9 2.1 33.3 2
10 4.9 7.3 1
11 6.7 10.8 1
12 13.8 58.1 1
13 7.6 6.0 1
14 25.5 87.4 1
15 2.5 11.8 1
16 0.6 5.8 1
17 4.9 22.3 2
18 12.2 33.7 2
19 5.6 40.9 2
20 0.2 12.6 1
21 0.9 41.8 1
22 0.4 17.7 2
23 2.7 10.1 1
24 3.6 25.2 2
25 5.6 13.9 2
26 2.5 36.8 2
27 4.4 0.2 2
28 3.0 31.5 1
29 2.7 15.0 2
30 4.6 5.3 1
31 1.0 16.0 1
32 1.0 17.3 1
33 4.8 8.3 1
34 3.1 18.4 1
35 6.1 26.5 2
36 2.0 14.0 2
Mean  S.D. 5.4  5.2 25.2  20.6
PET-AI: asymmetry index of thalamic glucose metabolism, SEF-AI: asymmetry
index of somatosensory-evoked magnetic ﬁelds, Group 1: concordant asymmetry
(AI with FDG-PET and MEG do not show the contralateral side of focus), Group 2:
discordant or paradoxical asymmetry (AI with either FDG-PET or MEG shows the
contralateral side of focus), negative value of AI: AI shows the contralateral side of
the focus, bold letters: signiﬁcant AI.
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contralateral hemisphere.
Normal control
The normal absolute value of tCMRgluc and ECDI was
determined in 12 healthy volunteers for each modality. The
asymmetry indices (AI%) of tCMRGluc (PET-AI) and ECDI (SEF-AI)
were calculated using the following formula: AI = (right  left)
 100/[(right + left)/2]. All volunteerswere free of any neurological
or psychological disease, and were not taking any anti-epileptic
drugs. Informed consent was obtained from each volunteer
after the purpose and procedures of the present study had been
explained.
Seizure outcome after epilepsy surgery
Postoperative seizure outcomewas assessed at least 24months
after surgery (range, 24–63 months; mean, 39.4 months). Seizure
outcomes were classiﬁed according to the classiﬁcation proposed
by the International League Against Epilepsy (ILAE)16: Class 1,
completely seizure-free; Class 2, aura alone with no seizure; Class
3, one to three seizure days/year; Class 4, 50% reduction in baseline
number of seizure days; Class 5, <50% reduction in baseline
number of seizure days and Class 6, >100% increase in baseline
number of seizure days.
Statistical analysis
The differences in PET-AI and SEF-AI between the patients and
normal controls were analyzed using the unpaired t-test. The
correlation between PET-AI and SEF-AI was analyzed using
Pearson’s correlation coefﬁcient. Non-parametric analysis with
Mann–Whitney’s U-test was used to compare the postoperative
seizure outcomes of the two independent patient groups. A
statistically signiﬁcant difference was deﬁned as p < 0.05. All data
were expressed as mean  standard deviation.
Results
Comparison of PET-AI and SEF-AI between patients and normal
controls
Quantitative analysis of PET-AI and SEF-AI in normal healthy
volunteers revealed that the mean values were 0.4  3.0% and
0.8  9.7%, respectively. The cut-off level for the normal range was
determined as the standard deviation; jPET-AIj > 3.0 and jSEF-
AIj > 9.7 were expressed as signiﬁcant asymmetry of PET-AI and
SEF-AI. Of the 36 patients with temporal lobe epilepsy, 21 patients
(58.3%) and 29 patients (81%) were out of the normal range for PET-AI
and SEF-AI, respectively (Table 2). Mean PET-AI in the patients was
5.4  5.2%, which was signiﬁcantly different to the normal controls
(p < 0.05), whereas mean SEF-AI was 25.2  20.6% (not signiﬁcantly
different). PET-AI was positive (indicative for epileptic focus) in 29 of
36 patients (80.6%), and negative in 7 patients (19.4%). SEF-AI was
positive in 17 of 36 patients (47.2%), and negative in 19 patients
(52.8%) (Table 2). No signiﬁcant correlation was noted between PET-
AI and SEF-AI in patients (r = 0.43) (Fig. 3).
Clinical impact of PET-AI and SEF-AI on surgical outcome
Patients were classiﬁed into two independent groups based on
PET-AI and SEF-AI: Group 1 and Group 2. In Group 1 (concordant
asymmetry group), both PET-AI and SEF-AI demonstrated more
than the negative value of the standard deviation (PET-AI > 3.0and SEF-AI > 9.7), which was indicative for ipsilateral epileptic
focus; in Group 2 (discordant or paradoxical asymmetry group),
either PET-AI or SEF-AI showed less than the negative value of the
standard deviation (PET-AI < 3.0 and SEF-AI < 9.7), being
indicative for contralateral epileptic focus (Fig. 3). Of the 36
patients, 21were classiﬁed as Group 1 and 15 as Group 2. Nineteen
(90.5%) of the 21 patients in Group 1 obtained a good seizure
outcome (ILAE Class 1–3), compared to 6 (40%) of the 15 patients in
Group 2. Regarding postoperative seizure outcome, patients in
Group 1 had signiﬁcantly better outcomes compared to patients in
Group 2 (p < 0.01) (Fig. 4).
Discussion
In the present study, careful preoperative analysis using FDG-
PET and MEG was conducted to predict postoperative seizure
outcome in 36 patients with drug-resistant medial temporal lobe
epilepsy. Although no signiﬁcant correlation between PET-AI and
SEF-AI was noted (r = 0.43), concordant asymmetry in both PET-AI
and SEF-AI was signiﬁcantly associated with better seizure
outcome than discordant or paradoxical asymmetry of both
factors (p < 0.01). Better understanding of diversity and complex-
ity of temporal lobe epilepsy may enable us to formulate goals for
surgical treatment.
Figure 3. Graph showing Group classiﬁcation based on PET-AI and SEF-AI. The non-
shaded area represents Group 1 (concordant asymmetry); the shaded area
represents Group 2 (discordant or paradoxical asymmetry). There was no
signiﬁcant correlation between PET-AI and SEF-AI with Pearson’s correlation
coefﬁcient (r = 0.43; n = 36). PET-AI: asymmetry index of cerebral metabolic rate of
glucose in the thalamus. SEF-AI: asymmetry index of equivalent current dipole
intensity of N20m. Group 1 (concordant asymmetry): PET-AI > S.D. and SEF-
AI > S.D. Group 2 (discordant or paradoxical asymmetry): PET-AI < S.D. or SEF-
AI < S.D.
S. Sakamoto et al. / Seizure 18 (2009) 1–6 5Extratemporal glucose metabolism in patients with temporal
lobe epilepsy has been well studied using FDG-PET; the existence
of thalamic glucose hypometabolism is considered to be associated
with the activity or progression of temporal lobe epilepsy.4,6,17–21
It is reported that thalamic glucose hypometabolism is well
correlated with the side of epileptogenic focus,22,23 as PET-AI
revealed the side of focus with statistical signiﬁcance in the
present study. It has been supposed that thalamic glucose
hypometabolism in temporal lobe epilepsy is attributable to
corticothalamic diaschisis. Extensive reciprocal connections
between the thalamus, hippocampal formation, amygdala, and
entorhinal cortexmay play a role in a secondary change in thalamic
glucose hypometabolism.6,20–23 However, the preoperative tha-Figure 4. Graph showing the comparison of outcomes proposed by the
International League Against Epilepsy (ILAE) between Groups 1 and 2 (n = 36).
Statistically signiﬁcant differences were recognized between Groups 1 and 2 using
the Mann–Whitney’s U-test (p < 0.01).lamic glucose hypometabolism did not appear to be correlated
with the postoperative seizure outcome in temporal lobe
epilepsy.24 This report implicates the diversity and complexity
of metabolism alternations associated with the epileptogenesis in
temporal lobe epilepsy.
Neuromagnetic recordings in temporal lobe epilepsy have
been studied in localizing the epileptogenic focuses.2,5–9,25–27 In
our previous report, the pattern of equivalent current dipole
distribution was seen to be non-uniform regardless of the typical
symptomatology of temporal lobe epilepsy; this suggests a
diverse and complex mechanism of interictal epileptic phenom-
ena in temporal lobe epilepsy.2 In the present study, SEF, ﬁrst
reported by Brenner et al. in 1978,28 was measured in patients
withmedically intractable temporal lobe epilepsy. The ECD of the
ﬁrst main component of SEF, having a latency of approximately
20 ms, is estimated as area 3b of the primary somatosensory
cortex (SI)29,30 and its absolute magnitude represents the cortical
or subcortical neural activity31–37; it may also have a potential to
detect the neural activity of thalamo-cortical neural pathway
including the somatosensory cortex.36–38 SEF-AI did not show the
side of epileptogenic focus with statistical signiﬁcance in the
present study. This result suggests the diversity and complexity of
neural activity in temporal lobe epilepsy and implies the diffuse
focuses over the bilateral cerebral hemispheres. Although the
measurement of SEF could be useful to estimate the thalamo-
cortical function, it may not be valid in some patients with diffuse
focuses.
Although no signiﬁcant relation was noted between PET-AI and
SEF-AI, the patients in Group 1 (PET-AI and SEF-AI concordant
asymmetry group) were revealed to have a signiﬁcantly better
outcome compared to the patients in Group 2 (PET-AI and SEF-AI
discordant or paradoxical asymmetry group) (p < 0.01). What is
the difference betweenGroups 1 and 2? It is reported that the focus
in temporal lobe epilepsy may progress from localized to diffuse,39
and that postoperative seizure outcome is improved in localized
epileptic focus compared to diffuse focus3–11; however, the
mechanism of epileptic focus progression and diffusion over time
remains unresolved. Morrell40 proposed the clinical concept of
secondary epileptogenesis which implies that an actively dischar-
ging epileptogenic region (primary focus), having massive
neuronal connections with some other site, may gradually
‘‘induce’’ similar paroxysmal behavior in the cellular elements of
the otherwise normal network (secondary focus). Not only the
thalamolimbic neural circuits but also the cerebral hemisphere,
which includes the sensory cortical area, is a part of the neural
network of the epileptic brain and possibly represents a secondary
focus in temporal lobe epilepsy.41,42 Furthermore, transcallosal
connectionmay have a signiﬁcant associationwith epileptogenesis
in the contralateral cerebrum.43,44 Considering the progression of
epileptogenesis in the present study, we speculate that patients in
Group 1 may have a localized epileptic focus, whereas patients in
Group 2 may have a diffuse epileptic focus.
The results of the present study, along with several previously
mentioned studies, support the clinical concept that temporal lobe
epilepsy may be a progressive and diffuse disease, and that
progression of epileptogenesis in the brain may affect the
postoperative seizure outcome, which is better for a localized
epileptic focus than a diffuse focus. Temporal lobe epilepsy is
thought to be a diffuse network disease. Surgical treatment may
play a role in removing the neural circuit responsible for secondary
epileptogenesis as well as resecting the primary epileptic focus;
this may be the reason that some patients with a diffuse epileptic
focus (Group 2) had good seizure outcome following surgery. Full
understanding requires careful investigation of the progression of
epileptogenesis.
S. Sakamoto et al. / Seizure 18 (2009) 1–66Conclusions
The results in the present study suggest that thalamic glucose
hypometabolism has a signiﬁcant relation with the epileptogenic
focus of temporal lobe epilepsy, and is associated with the diverse
and complex involvement of thalamo-cortical neural pathway.
Although prediction of postoperative seizure outcome is not
straightforward, quantitative analysis of thalamic glucose meta-
bolism along with equivalent current dipole intensity of somato-
sensory-evokedmagnetic ﬁeldsmay be of use in characterizing the
preoperative epileptogenic condition and postoperative seizure
outcome. A constellation of developmental brain abnormalities
and environmental factors that together produce epilepsy need to
be further explored.
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